...using Redwood's SMARTag technology. Catalent declined to disclose financial details (see BioCentury, April 15, 2013). Redwood Bioscience Inc....

...also has an ADC discovery and development deal with Celgene Corp. Like Ambrx and Sutro, Redwood Bioscience Inc....
...Inc. , Cambridge, Mass. Pfizer Inc. (NYSE:PFE), New York, N.Y. PolyTherics Ltd. , London, U.K. Redwood Bioscience Inc....
...payload to mAb NA (co provides drug discovery services and does no internal drug development) Redwood Bioscience Inc....

...provide details, and Redwood could not be reached. Catalent Pharma Solutions Inc. , Somerset, N.J. Redwood Bioscience Inc....

...Allozyne's programs are in discovery, and Sutro hasn't disclosed the development status of its programs. Redwood Bioscience Inc....
...NYSE:MRK), Whitehouse Station, N.J. Merck KGaA (Xetra:MRK), Darmstadt, Germany Pfizer Inc. (NYSE:PFE), New York, N.Y. Redwood Bioscience Inc....

...companies are developing methods that provide greater control over where the toxin payloads are attached. Redwood Bioscience Inc....
...Seattle, Wash. Genentech Inc. , South San Francisco, Calif. ImmunoGen Inc. (NASDAQ:IMGN), Waltham, Mass. Redwood Bioscience Inc....
...Biopharma Inc. , South San Francisco, Calif. University of California, Berkeley , Berkeley, Calif. Sidebars Redwood Bioscience Inc....

...SciBX 2(4); doi:10.1038/scibx.2009.161 Published online Jan. 29, 2009 Worldwide patent application filed; exclusively licensed to Redwood Bioscience Inc....